Skip Navigation

 

Funding Opportunities

Please visit the Funding Opportunities section of this website often to view specific research and training opportunities.

American Recovery and Reinvestment Act of 2009 (ARRA)
The NCI has launched a dedicated Web site in response to the American Recovery and Reinvestment Act of 2009 (ARRA). Funding announcements on this page are grouped into categories, with various deadlines:

  • Challenge Grants
  • Grand Opportunities (GO)
  • Core Center Grants (P30)
  • Competitive Revisions and Administrative Supplements
  • Construction/Renovation
  • Instrumentation

Grand Opportunities (GO) Grants – RFA-OD-09-004
Receipt date: May 27, 2009
The Grand Opportunities (GO) grants – RFA-OD-09-004, specifically target research topics of interest (Proteomics, Nanotechnology, Stem Cells, Early Phase Clinical Trials, Transcriptional and Translational Regulation, Comparative Oncology Research).

NIH Challenge Grants in Health and Science Research (RC1)
Receipt date: April 27, 2009
NIH has identified 15 Broad Challenge Areas, of which several include Specific Challenge Topics of direct interest to you and your community (some developed by NCI's Clinical Proteomic Technologies for Cancer). They are clinical proteomics; reagents & resources development (antibodies and libraries); mitochondrial research; biospecimens; biomarkers; advanced technologies; cancer stem cells; drug research, and ethical issues. Those areas marked with an asterisk (*) have been identified by the NIH as high priority topics. In addition, Institutes and Centers have identified additional Challenge Topics for funding under this FOA.


Underrepresented Minority Training Grants
The NCI’s Diversity Training Branch has several grant supplements that are available to help develop specialized personnel that are members of underserved communities.  These supplements are not limited by educational status: They are offered to trainees at various levels in their professional careers and awards are available for high school students through junior investigators. In applying for each grant, indicate that it is for Clinical Proteomic Technology in support of NCI's Clinical Proteomic Technologies for Cancer Initiative.

Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships (F31) to Promote Diversity in Health-Related Research
PA Number: PA-07-106
Receipt Dates: April 13; August 13; December 13
Expiration Date: April 14, 2010


Proteomic Reagents and Resource Core
The Proteomic Reagents and Resource Core will organize tools, reagents, and enabling technologies to support protein/peptide measurement and analysis efforts. These highly purified and characterized reagents would be used to develop improved approaches to sample preparation, fractionation, separation, detection, and quantification, as well as equipment standardization and calibration. The Core will serve as a central (virtual) source for reagents for the scientific community and will include human and mouse tissue samples, and plasma, antibodies and affinity capture reagents, labeling reagents, protein and/or peptide mixtures, and other reagents needed for effective proteomic analysis platforms. The Core does not intend to provide materials that are commercially available unless it is suspected that significant variation occurs between commercial lots (e.g., polyclonal antibodies).

To learn more about the National Institutes of Health grant programs, please visit the NIH Forms and Grant Applications website.